-
Trusted Abroad, Blocked at Home: Why Americans Need a Passport for Proven Medicines
21 Aug 2025 04:33 GMT
… drugs does the Food and Drug Administration (FDA) block patients and doctors … FDA required additional clinical trials. The FDA … Drug loss occurs when pharmaceutical companies decide not to pursue promising treatments … to medicines: international drug reciprocity …
-
Phase 2/3 Trial Further Evaluates Ficerafusp Alfa With Pembrolizumab in HPV– Head and Neck Cancer
18 Aug 2025 17:22 GMT
… trial] is to establish a new standard of care for the treatment … agents actively in clinical trials that are progressing into … in line with the FDA’s Project Optimus, 2 … , and other chemotherapy drugs, including capecitabine [Xeloda], for instance. That …
-
<![CDATA[A Patient Guide to Understanding HER2-Positive Breast Cancer]]>
20 Sep 2025 00:30 GMT
… drug conjugates, or clinical trial options.
Metastatic HER2-Positive Breast Cancer Treatment … Third-line and beyond: Xeloda (capecitabine) plus Tukysa … trastuzumab emtansine); clinical trials are also an option … substitute for professional medical advice. Please …
-
What You Need to Know About Breast Cancer Chemotherapy Pills
01 Jul 2025 14:46 GMT
… their treatment plan:
chemotherapy pills
antihormone pills
targeted therapy (precision medicine) pills
Each … like warfarin, your doctor may need to monitor … Xeloda) and cyclophosphamide (Cytoxan) are chemotherapy drugs available in pill form for the treatment …
-
Zanidatamab Plus Chemotherapy Shows Promising Anti-Tumor Activity in Treatment of HER2-Mutated Breast Cancer
21 May 2025 23:08 GMT
Zanidatamab (Ziihera; Jazz Pharmaceuticals, Inc) plus chemotherapy … the European Society for Medical Oncology Breast Cancer 2025 … as a treatment for HER2-mutated BCs. The trial is divided … neratinib (7%; Nerlynx; Puma Biotechnology). Patients with HER2-low mBC …
-
Outcomes of Pharmacist-Driven Clinical Interventions in a Medically Integrated Oncology Specialty Pharmacy Practice
15 Apr 2025 15:06 GMT
… to clinical trials in their … medication program improves identification of potential drug interactions, patient understanding of their treatment … (eg, capecitabine [Xeloda; Genentech], venetoclax [ … Pharmaceuticals Corp; 2024. https://www.accessdata.fda …
-
[Interview] Novel immunotherapy nelmastobart shows promise in MSS colorectal cancer: early trial data
28 Feb 2025 10:38 GMT
… the Department of Medical Oncology and … monotherapy, and although Xeloda (ingredient: capecitabine) … with multinational pharmaceutical companies.
For this new trial, nelmastobart … drugs that surpass oxaliplatin or irinotecan in MSS colorectal cancer treatment …
-
Breaking Down the FDA Labeling Update of Xeloda and 5-FU in Cancer Care
10 Feb 2025 22:25 GMT
… to treatment.
Brooks is an associate professor of medicine and … deficiency before starting treatment with fluorouracil or Xeloda?
The best … do chemotherapy treatment with 5-FU or Xeloda, as soon … doctors, as advised on the FDA drug labels for 5-FU and Xeloda …
-
An Expert Breaks Down What DPD Is and Labeling Updates From The FDA
10 Feb 2025 22:25 GMT
… Drug Administration (FDA), the labeling for Xeloda (capecitabine) and fluorouracil (5-FU) chemotherapy treatment … , at Dartmouth Geisel School of Medicine, in Lebanon, New Hampshire.
… discussion with your doctor and understanding that your doctor may not be …
-
FDA Approves T-DXd in HR+, HER2-Low/Ultralow Breast Cancer
28 Jan 2025 00:55 GMT
… The FDA has approved trastuzumab deruxtecan for the treatment of … FASCO, professor, department of medicine, division of hematology/ … on the DESTINY-Breast04 trial (NCT03734029).3 Notably, … which consisted of capecitabine (Xeloda; 59.8%), nab-paclitaxel …